Masuda T - Search Results

1

Development of an intraoperative breast cancer margin assessment method using quantitative fluorescence measurements.

Ueo H, Minoura I, Ueo H, Gamachi A, Kai Y, Kubota Y, Doi T, Yamaguchi M, Yamashita T, Tsuda H, Moriya T, Yamaguchi R, Kozuka Y, Sasaki T, Masuda T, Urano Y, Mori M, Mimori K. Ueo H, et al. Among authors: masuda t. Sci Rep. 2022 May 20;12(1):8520. doi: 10.1038/s41598-022-12614-6. Sci Rep. 2022. PMID: 35595810 Free PMC article.

2

Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay.

Mimori K, Matsuyama A, Yoshinaga K, Yamashita K, Masuda T, Inoue H, Ueo H, Mori M. Mimori K, et al. Among authors: masuda t. Oncology. 2002;62(4):327-32. doi: 10.1159/000065064. Oncology. 2002. PMID: 12138240

3

MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway.

Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, Masuda T, Utsunomiya T, Alonso MA, Inoue H, Mori M. Mimori K, et al. Among authors: masuda t. Oncogene. 2003 May 29;22(22):3463-71. doi: 10.1038/sj.onc.1206378. Oncogene. 2003. PMID: 12776198

4

N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.

Yoshinaga K, Inoue H, Utsunomiya T, Sonoda H, Masuda T, Mimori K, Tanaka Y, Mori M. Yoshinaga K, et al. Among authors: masuda t. Clin Cancer Res. 2004 Sep 1;10(17):5702-7. doi: 10.1158/1078-0432.CCR-03-0262. Clin Cancer Res. 2004. PMID: 15355896

5

Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.

Masuda TA, Kataoka A, Ohno S, Murakami S, Mimori K, Utsunomiya T, Inoue H, Tsutsui S, Kinoshita J, Masuda N, Moriyama N, Mori M. Masuda TA, et al. Among authors: masuda n. Int J Oncol. 2005 Mar;26(3):721-30. Int J Oncol. 2005. PMID: 15703829

6

Significance of skp2 expression in primary breast cancer.

Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M. Sonoda H, et al. Among authors: masuda ta. Clin Cancer Res. 2006 Feb 15;12(4):1215-20. doi: 10.1158/1078-0432.CCR-05-1709. Clin Cancer Res. 2006. PMID: 16489076

7

[Occult micrometastasis].

Masuda T, Mimori K, Mori M. Masuda T, et al. Nihon Rinsho. 2006 Mar;64(3):442-9. Nihon Rinsho. 2006. PMID: 16529034 Review. Japanese.

8

Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.

Ueda M, Iguchi T, Nambara S, Saito T, Komatsu H, Sakimura S, Hirata H, Uchi R, Takano Y, Shinden Y, Eguchi H, Masuda T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K. Ueda M, et al. Among authors: masuda t. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1490-8. doi: 10.1245/s10434-015-4652-7. Epub 2015 Jun 3. Ann Surg Oncol. 2015. PMID: 26036188

9

Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients.

Sugimachi K, Sakimura S, Tomokuni A, Uchi R, Hirata H, Komatsu H, Shinden Y, Iguchi T, Eguchi H, Masuda T, Morita K, Shirabe K, Eguchi H, Maehara Y, Mori M, Mimori K. Sugimachi K, et al. Among authors: masuda t. J Clin Med. 2015 Aug 14;4(8):1600-11. doi: 10.3390/jcm4081600. J Clin Med. 2015. PMID: 26287250 Free PMC article.

10

Clinical Significance of Expression of Nephroblastoma Overexpressed (NOV) in Patients with Colorectal Cancer.

Ueda M, Iguchi T, Komatsu H, Kidogami S, Hu Q, Sato K, Ogawa Y, Nambara S, Saito T, Sakimura S, Hirata H, Uchi R, Shinden Y, Eguchi H, Ito S, Masuda T, Yamamoto H, Doki Y, Mori M, Mimori K. Ueda M, et al. Among authors: masuda t. Anticancer Res. 2015 Dec;35(12):6591-7. Anticancer Res. 2015. PMID: 26637874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,279 results

Search Page